vs

Side-by-side financial comparison of Surrozen, Inc. (SRZN) and Terra Property Trust, Inc. (TPTA). Click either name above to swap in a different company.

Surrozen, Inc. is the larger business by last-quarter revenue ($10.0M vs $7.1M, roughly 1.4× Terra Property Trust, Inc.). Surrozen, Inc. runs the higher net margin — -14.3% vs -150.2%, a 135.9% gap on every dollar of revenue.

Surrozen, Inc. is a clinical-stage biotechnology company dedicated to developing targeted regenerative therapies based on the Wnt signaling pathway. Its product pipeline covers unmet medical needs in ophthalmology, gastrointestinal diseases and other severe chronic conditions, serving global patient groups and collaborating with industry partners to advance innovative treatment accessibility.

The National Savings and Trust Company is a historic bank building located at the corner of New York Avenue and 15th Street, NW in Downtown Washington, D.C. It has also been known as the National Safe Deposit Company and the National Safe Deposit Savings and Trust Company.

SRZN vs TPTA — Head-to-Head

Bigger by revenue
SRZN
SRZN
1.4× larger
SRZN
$10.0M
$7.1M
TPTA
Higher net margin
SRZN
SRZN
135.9% more per $
SRZN
-14.3%
-150.2%
TPTA

Income Statement — Q3 FY2024 vs Q4 FY2025

Metric
SRZN
SRZN
TPTA
TPTA
Revenue
$10.0M
$7.1M
Net Profit
$-1.4M
$-10.6M
Gross Margin
Operating Margin
12.3%
-48.8%
Net Margin
-14.3%
-150.2%
Revenue YoY
-37.4%
Net Profit YoY
86.3%
32.0%
EPS (diluted)
$-0.44
$-0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SRZN
SRZN
TPTA
TPTA
Q4 25
$7.1M
Q3 25
$7.3M
Q2 25
$8.6M
Q1 25
$12.5M
Q4 24
$11.3M
Q3 24
$10.0M
$12.2M
Q2 24
$0
$11.2M
Q1 24
$0
$15.0M
Net Profit
SRZN
SRZN
TPTA
TPTA
Q4 25
$-10.6M
Q3 25
$-6.7M
Q2 25
$-9.2M
Q1 25
$-1.3M
Q4 24
$-15.6M
Q3 24
$-1.4M
$-7.8M
Q2 24
$-25.3M
$-7.5M
Q1 24
$-8.8M
$-6.2M
Operating Margin
SRZN
SRZN
TPTA
TPTA
Q4 25
-48.8%
Q3 25
6.7%
Q2 25
-28.4%
Q1 25
32.8%
Q4 24
-72.3%
Q3 24
12.3%
54.1%
Q2 24
6.3%
Q1 24
32.0%
Net Margin
SRZN
SRZN
TPTA
TPTA
Q4 25
-150.2%
Q3 25
-92.4%
Q2 25
-106.5%
Q1 25
-10.3%
Q4 24
-138.3%
Q3 24
-14.3%
-63.9%
Q2 24
-67.5%
Q1 24
-41.2%
EPS (diluted)
SRZN
SRZN
TPTA
TPTA
Q4 25
$-0.43
Q3 25
$-0.28
Q2 25
$-0.38
Q1 25
$-0.05
Q4 24
$-0.65
Q3 24
$-0.44
$-0.32
Q2 24
$-7.99
$-0.31
Q1 24
$-4.24
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SRZN
SRZN
TPTA
TPTA
Cash + ST InvestmentsLiquidity on hand
$31.0M
$33.2M
Total DebtLower is stronger
$178.9M
Stockholders' EquityBook value
$5.7M
$146.5M
Total Assets
$48.0M
$351.5M
Debt / EquityLower = less leverage
1.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SRZN
SRZN
TPTA
TPTA
Q4 25
$33.2M
Q3 25
$17.4M
Q2 25
$5.9M
Q1 25
$11.9M
Q4 24
$8.6M
Q3 24
$31.0M
$21.2M
Q2 24
$37.8M
$18.9M
Q1 24
$27.3M
$17.9M
Total Debt
SRZN
SRZN
TPTA
TPTA
Q4 25
$178.9M
Q3 25
$211.9M
Q2 25
$260.2M
Q1 25
$286.7M
Q4 24
$326.1M
Q3 24
$312.9M
Q2 24
$383.8M
Q1 24
$377.6M
Stockholders' Equity
SRZN
SRZN
TPTA
TPTA
Q4 25
$146.5M
Q3 25
$159.7M
Q2 25
$168.5M
Q1 25
$179.9M
Q4 24
$185.7M
Q3 24
$5.7M
$206.2M
Q2 24
$6.1M
$218.6M
Q1 24
$30.1M
$230.5M
Total Assets
SRZN
SRZN
TPTA
TPTA
Q4 25
$351.5M
Q3 25
$398.1M
Q2 25
$459.3M
Q1 25
$495.2M
Q4 24
$542.8M
Q3 24
$48.0M
$546.8M
Q2 24
$45.1M
$634.4M
Q1 24
$36.7M
$640.2M
Debt / Equity
SRZN
SRZN
TPTA
TPTA
Q4 25
1.22×
Q3 25
1.33×
Q2 25
1.54×
Q1 25
1.59×
Q4 24
1.76×
Q3 24
1.52×
Q2 24
1.76×
Q1 24
1.64×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SRZN
SRZN
TPTA
TPTA
Operating Cash FlowLast quarter
$-6.8M
$1.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SRZN
SRZN
TPTA
TPTA
Q4 25
$1.9M
Q3 25
$-4.3M
Q2 25
$1.2M
Q1 25
$861.6K
Q4 24
$-3.3M
Q3 24
$-6.8M
$1.7M
Q2 24
$-5.6M
$-3.1M
Q1 24
$-8.7M
$-4.2M
Free Cash Flow
SRZN
SRZN
TPTA
TPTA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
$-8.8M
Capex Intensity
SRZN
SRZN
TPTA
TPTA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.0%
Q3 24
0.0%
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons